-
O126519-5gOlanzapine is a high affinity for 5-HT2 serotonin and D2 dopamine receptor antagonist.Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective
-
O129301-10mgOlmesartan Medoxomil is a compound which is hydrolyzed to olmesartan that is a selective AT1 subtype angiotensin II receptor antagonist.An angiotensin II receptor antagonist
-
O129301-1gOlmesartan Medoxomil is a compound which is hydrolyzed to olmesartan that is a selective AT1 subtype angiotensin II receptor antagonist.An angiotensin II receptor antagonist
-
O129301-250mgOlmesartan Medoxomil is a compound which is hydrolyzed to olmesartan that is a selective AT1 subtype angiotensin II receptor antagonist.An angiotensin II receptor antagonist
-
O129301-50mgOlmesartan Medoxomil is a compound which is hydrolyzed to olmesartan that is a selective AT1 subtype angiotensin II receptor antagonist.An angiotensin II receptor antagonist
-
O129301-5gOlmesartan Medoxomil is a compound which is hydrolyzed to olmesartan that is a selective AT1 subtype angiotensin II receptor antagonist.An angiotensin II receptor antagonist
-
O159894-1gSelective H 1 receptor antagonist
-
O159894-250mgSelective H 1 receptor antagonist
-
O159894-25gSelective H 1 receptor antagonist
-
O159894-5gSelective H 1 receptor antagonist
-
O124003-100mgOxaliplatin is a second generation potent platinum-based anti-neoplastic agent that is believed to form inter- and intrastrand DNA adducts which activate signaling pathways culminating in apoptosis. The development of Oxaliplatin was inspired from
-
O124003-1gOxaliplatin is a second generation potent platinum-based anti-neoplastic agent that is believed to form inter- and intrastrand DNA adducts which activate signaling pathways culminating in apoptosis. The development of Oxaliplatin was inspired from